Supernus Pharmaceuticals in Rockville filed to raise $100 million in an IPO. The company is working on drugs to treat central nervous system disorders, including epilepsy and attention deficit disorder.
[From WaPo]
Supernus Pharmaceuticals in Rockville filed to raise $100 million in an IPO. The company is working on drugs to treat central nervous system disorders, including epilepsy and attention deficit disorder.
[From WaPo]